2015
DOI: 10.1016/j.ejphar.2015.03.002
|View full text |Cite
|
Sign up to set email alerts
|

Magnolol and honokiol regulate the calcium-activated potassium channels signaling pathway in Enterotoxigenic Escherichia coli-induced diarrhea mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
26
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 31 publications
(27 citation statements)
references
References 38 publications
1
26
0
Order By: Relevance
“…Magnolol is not only an anti-inflammatory agent but also a modulator on gastrointestinal motility, which is supported by the findings that: (1) magnolol suppresses pro-inflammatory cytokines and modulates the related pathways in vitro [ 23 , 24 , 25 ]; (2) magnolol exhibits significant therapeutic effects on animal models with different inflammatory diseases [ 11 , 13 , 14 , 26 ]; (3) magnolol exerts inhibitory effects on the smooth muscle contraction of gastric, ileum and colon [ 19 , 27 ]; (4) interestingly, magnolol shows stimulatory effects on gastrointestinal motility at lower dosages [ 22 , 28 ]; (5) magnolol regulates the calcium-activated potassium channels signaling pathway in the enterotoxigenic Escherichia coli-induced diarrhea mice [ 29 ]. These evidences indicate that magnolol have potential value in the treatment of gastroenterology disorders caused by intestinal inflammation or diarrhea such as colitis.…”
Section: Discussionmentioning
confidence: 99%
“…Magnolol is not only an anti-inflammatory agent but also a modulator on gastrointestinal motility, which is supported by the findings that: (1) magnolol suppresses pro-inflammatory cytokines and modulates the related pathways in vitro [ 23 , 24 , 25 ]; (2) magnolol exhibits significant therapeutic effects on animal models with different inflammatory diseases [ 11 , 13 , 14 , 26 ]; (3) magnolol exerts inhibitory effects on the smooth muscle contraction of gastric, ileum and colon [ 19 , 27 ]; (4) interestingly, magnolol shows stimulatory effects on gastrointestinal motility at lower dosages [ 22 , 28 ]; (5) magnolol regulates the calcium-activated potassium channels signaling pathway in the enterotoxigenic Escherichia coli-induced diarrhea mice [ 29 ]. These evidences indicate that magnolol have potential value in the treatment of gastroenterology disorders caused by intestinal inflammation or diarrhea such as colitis.…”
Section: Discussionmentioning
confidence: 99%
“…The commercial magnolol power (extracted from the cortex of Magnolia officinalis, purity > 98.0 % in dry) was purchased from Jinnong Bio Co. Ltd. (Changsha, China) and kept at -20°C. The ETEC O 78 :K 80 (44813) suspensions (3.45×109 CFU/ml) was prepared in accordance with our previous report [44], and cultured overnight in lysogeny broth (LB) medium in a shaking incubator at 180 rpm and 37°C for 12 h. The cell density of ETEC suspension was measured by ND-1000 UV-vis spectrophotometer (Nano-Drop Ltd., TX).…”
Section: Extracts and Reagentsmentioning
confidence: 99%
“…The commercial magnolol power was equally dissolved in 0.4 ml 2% Tween 80 solution before oral administration by gavage for each mouse. The ETEC suspension was prepared according to our previous report [44], and the density was measured with ND-1000 UV-vis spectrophotometer (NanoDrop Ltd., TX) at optical density 600 (OD 600=1 represents 1 × 10 10 CFU/ml cell density). In the present study, the determined cell density of ETEC suspension was 3.45×10 9 CFU/ml.…”
Section: Experimental Designmentioning
confidence: 99%
See 2 more Smart Citations